Combined MEK and JAK/STAT3 Pathway Inhibition Effectively Decreases SHH Medulloblastoma Tumor Progression

Scientists demonstrated that the MEK inhibitor, selumetinib, decreased human Sonic Hedgehog medulloblastoma growth while extending survival in mouse models.